Literature DB >> 1426700

Severe exacerbation of chronic active hepatitis B during interferon alpha therapy.

T Laskus1, M Radkowski, J Slusarczyk, J Cianciara.   

Abstract

The case of a 52-year-old male with chronic active type B hepatitis in whom severe exacerbation of liver disease was associated with interferon alpha treatment is described. It seems that patients with very active forms of chronic hepatitis B may experience severe and symptomatic exacerbation of liver disease during interferon treatment.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1426700     DOI： 10.1159/000200940

Source DB:  PubMed          Journal:  Digestion        ISSN： 0012-2823            Impact factor:   3.216


  3 in total

1.  Current Options for the Therapy of Chronic Hepatitis B Infection.

Authors:  Suzane Kioko Ono-Nita; Naoya Kato; Yasushi Shiratori; Masao Omata
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 2.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

3.  Severe acute exacerbation of chronic hepatitis B during pegylated interferon treatment and early intervention with corticosteroid.

Authors:  Qing Mao; Hui-Yan Zhang; Jian-Ping You; Xu-Qing Zhang
Journal:  Virol J       Date:  2012-07-24       Impact factor: 4.099
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.